Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Alkermes Plc
ALKSCurrent price
27.88 USD
-0.34 USD (-1.20%)
Last closed
28.04 USD
Company
www.alkermes.com
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Capitalization
4 201 757 184 USD
Yield for 12 month
-7.93 %
1Y
3Y
5Y
10Y
15Y
ALKS
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. Address: Connaught House, Dublin, Ireland, D04 C5Y6
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
34.67 USDP/E ratio
7.3899Dividend Yield
–Current Year
+1 663 405 000 USD
Last Year
+1 111 795 000 USD
Current Quarter
+350 372 000 USD
Last Quarter
+377 475 000 USD
Current Year
+1 374 679 000 USD
Last Year
+893 687 000 USD
Current Quarter
+289 269 000 USD
Last Quarter
+298 353 000 USD
Key Figures ALKS
1 year
3 years
5 years
10 years
EBITDA
538 672 000 USD
Operating Margin TTM
PE Ratio
7.3899
Return On Assets TTM
14.65 %
PEG Ratio
-1057.29
Return On Equity TTM
50.45 %
Wall Street Target Price
34.67 USD
Revenue TTM
1 726 182 016 USD
Book Value
7.42 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
21.8 %
Dividend Yield
–
Gross Profit TTM
893 687 000 USD
Earnings per share
3.36 USD
Diluted Eps TTM
3.36 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
25.17 %
Dividend Analytics ALKS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALKS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
2:1
Payout Ratio
–
Last Split Date
15.05.2000
Dividend Date
–
Stock Valuation ALKS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
7.3899
Forward PE
9.5511
Enterprise Value Revenue
2.2115
Price Sales TTM
2.4528
Enterprise Value EBITDA
7.0815
Price Book MRQ
3.3924
Financials ALKS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALKS
For 52 weeks
22.01 USD
32.88 USD
50 Day MA
24.22 USD
Shares Short Prior Month
11 957 724
200 Day MA
25.85 USD
Short Ratio
6.44
Shares Short
13 676 118
Short Percent
11.81 %
BeatStart